These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1426662)

  • 1. Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
    Chihara G
    Dev Biol Stand; 1992; 77():191-7. PubMed ID: 1426662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.
    Chihara G; Hamuro J; Maeda YY; Shiio T; Suga T; Takasuka N; Sasaki T
    Cancer Detect Prev Suppl; 1987; 1():423-43. PubMed ID: 3319150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation and consideration of BRM-BRM and HDP (host defense potentiators)].
    Chihara G
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1588-96. PubMed ID: 3382231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
    Taguchi T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
    Suga T; Shiio T; Maeda YY; Chihara G
    Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
    Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
    Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of lentinan in animal models.
    Chihara G
    Adv Exp Med Biol; 1983; 166():189-97. PubMed ID: 6606302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
    Kosaka A; Wani T; Hattori Y; Yamashita A
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1474-81. PubMed ID: 6764117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
    Akimoto M; Nishihira T; Mori S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of Madison 109 lung carcinoma and other murine tumors using lentinan.
    Rose WC; Reed FC; Siminoff P; Bradner WT
    Cancer Res; 1984 Apr; 44(4):1368-73. PubMed ID: 6704958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
    Akimoto M; Nishihira T; Kasai M
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1270-6. PubMed ID: 3729450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of phase III study of lentinan].
    Taguchi T; Furue H; Kimura T; Kondo T; Hattori T; Itoh I; Ogawa N
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):366-78. PubMed ID: 3918510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental studies on growth inhibition and regression of cancer metastases].
    Chihara G
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1196-209. PubMed ID: 4004287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status and perspectives of immunomodulators of microbial origin.
    Chihara G; Maeda YY; Hamuro J
    Int J Tissue React; 1982; 4(3):207-25. PubMed ID: 6815071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor].
    Shiio T; Ohishi K; Tsuchiya Y; Niitsu I; Hayashibara H; Yoshihama T; Moriyuki H
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):475-9. PubMed ID: 3348633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-cancer effects of BRMs associated with nutrition in cancer patients].
    Nishihira T; Akimoto M; Mori S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1615-20. PubMed ID: 3382233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case report of advanced gastric cancer remarkably responding to mitomycin C, aclacinomycin A, SF-SP and lentinan combination therapy].
    Maekawa S; Saku M; Kinugasa T; Yoshida Y; Ikejiri K; Yakabe S
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):137-40. PubMed ID: 2105085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan.
    Herlyn D; Kaneko Y; Powe J; Aoki T; Koprowski H
    Jpn J Cancer Res; 1985 Jan; 76(1):37-42. PubMed ID: 3918909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
    Taguchi T
    Cancer Detect Prev Suppl; 1987; 1():333-49. PubMed ID: 3121179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denaturation and renaturation of a beta-1,6;1,3-glucan, lentinan, associated with expression of T-cell-mediated responses.
    Maeda YY; Watanabe ST; Chihara C; Rokutanda M
    Cancer Res; 1988 Feb; 48(3):671-5. PubMed ID: 2446749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.